Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Celestia S. Higano
Based on 133 articles published since 2007
||||
Expertise Level
The expertise of Celestia S. Higano ranks in the
  • Top 0.0093%
  • ... of 129,228 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 133 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Higano, C   ·   Higano, C S   ·   Higano, Celestia S   ·   Higano, Celestia
Work Locations
Details
Most likely:    University of Washington   Contact    
2018
  • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, University of Washington, Seattle, Washington. · Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · US Oncology, Las Vegas, Nevada. · Northwestern University, Feinberg School of Medicine, Chicago, Illinois. · CHRISTUS Santa Rosa Medical Center Hospital, San Antonio, Texas. · Departments of Internal Medicine and Biomedical Engineering, Center for Computational Medicine and Bioinformatics, Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan. · Pubmed 29105802
2017
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Centre for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada. · Vancouver Prostate Centre, Gordon and Leslie Diamond Health Care Centre, Vancouver General Hospital, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Pubmed 28516513
  • Department of Urology, University of Washington, Seattle, Washington. · Puget Sound Veteran Administration, Seattle, Washington. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Pubmed 28156002
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
  • University of Colorado Cancer Center, Medical Oncology, Aurora, CO. Electronic address: · SmartAnalyst Inc., New York, NY. · Janssen Global Services, Global Medical Affairs, Raritan, NJ. · Janssen Global Services, Global Market Access Analytics, Raritan, NJ. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · Pubmed 27876504
2016
  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Electronic address: · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Cancer Centers of North Carolina, Raleigh, NC, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · University of Wisconsin Carbone Cancer Center, Madison, WI, USA. · Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Aragon Pharmaceuticals, San Diego, CA, USA. · Janssen Research & Development, Spring House, PA, USA. · Janssen Biologics, B.V., Leiden, The Netherlands. · Janssen Research & Development, Los Angeles, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Pubmed 27160947
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Clinical Development, OncoGenex Pharmaceuticals, Inc., Bothell, USA. · Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver. · Department of Medical Oncology, Juravinski Cancer Centre, Hamilton, Canada. · Pubmed 27022067
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Pubmed 26552421
  • Group Health Research Institute, Seattle, WA. · University of Washington, Seattle, WA. · University of Washington, Seattle, WA;; VA Puget Sound Health Services Research & Development, Seattle, WA. · University of Houston, Houston, TX. · Fred Hutchinson Cancer Research Center. · Pubmed 28269902
  • Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, Departments of Medicine and Urology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle. · Pubmed 27560985
  • Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington. · Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Pubmed 27324988
  • University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 27072384
  • Department of Urology, University of Washington, Seattle, Washington. · Fred Hutchinson Cancer Research Center, Seattle, Washington. · State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau (SAR), China. · Department of Pathology, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Department of Veterans Affairs Medical Center, Seattle, Washington. · Janssen Research and Development, LLC, Spring House, Pennsylvania. · Uniformed Services University of the Health Sciences, Rockville, Maryland. · Georgetown University Medical Center, Washington, District of Columbia. · Pubmed 26990456
  • Department of Genome Sciences, University of Washington, Seattle, Washington, USA. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Department of Urology, University of Washington, Seattle, Washington, USA. · Department of Pathology, University of Washington, Seattle, Washington, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Department of Medicine, University of Washington, Seattle, Washington, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Pubmed 26928463
  • Genitourinary Cancer Research Laboratory, Department of Urology, University of Washington, Box 356510, Seattle, WA, 98195, USA. · Divison of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Divison of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Pathology, University of Washington, Seattle, WA, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · Department of Veterans Affairs Medical Center, Seattle, WA, USA. · Genitourinary Cancer Research Laboratory, Department of Urology, University of Washington, Box 356510, Seattle, WA, 98195, USA. · Pubmed 26667932
2015
  • Department of Urologic Oncology, School of Medicine, University of Colorado Denver, Aurora, Colorado. Electronic address: · Division of Medical Oncology, Department of Medicine and Department of Urology, School of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Smilow Cancer Center, Yale University, New Haven, Connecticut. · Pubmed 26196735
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States. Electronic address: · Memorial Sloan-Kettering, New York, NY, United States. · University of Wisconsin, Carbone Cancer Center, Madison, WI, United States. · Duke Cancer Institute and Duke Prostate Center, Duke University, Durham, NC, United States. · Thomas Jefferson University, Philadelphia, PA, United States. · New York University Clinical Cancer Center, New York, NY, United States. · Sarah Cannon Research Institute, Nashville, TN, United States. · Eli Lilly and Company, Bridgewater, NJ, United States. · Eli Lilly and Company, Indianapolis, IN, United States. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. · Pubmed 26082390
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • University of Washington, Seattle, Washington · Department of Biostatistics and Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island. · University of Washington, Seattle, Washington. · Duke University, Durham, North Carolina. · Oregon Health & Science University, Portland, Oregon. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Pennsylvania, Philadelphia, Pennsylvania. · American College of Radiology Imaging Network (ACRIN), Philadelphia, Pennsylvania; and. · University of California San Francisco, San Francisco, California. · Pubmed 25635138
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • Case Western Reserve University School of Medicine, Cleveland, OH. · Fred Hutchinson Cancer Research Center, Biostatistics and Biomathematics Program, Public Health Sciences Division, Seattle, WA. · University of Washington/Fred Hutchinson Cancer Research Center, Department of Medicine, Division of Oncology, Seattle, WA. · University of Washington/Fred Hutchinson Cancer Research Center, Department of Medicine, Division of Oncology, Seattle, WA. Electronic address: · Pubmed 25242417
  • Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Program, Massachusetts General Hospital, Boston, MA, USA. · Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Clinical Development, Exelixis, Inc., South San Francisco, CA, USA. · Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Genitourinary Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Urologic Surgery and Oncology, University of California San Francisco, San Francisco, CA, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pinnacle Oncology Hematology, Scottsdale, AZ, USA. · Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24631409
  • Departments of Medicine and Urology, University of Washington, 825 Eastlake Avenue East, Seattle, WA 98109-1023, USA. · Pubmed 26526753
  • Institute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan. · Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan. · Department of Urology, JCHO Tokyo Shinjuku Medical Center, Japan Community Health Care Organization Tokyo, Japan. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Institute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan; Graduate School of Engineering, The University of Tokyo, Tokyo, Japan. · Pubmed 26107379
  • Department of Urology, University of Washington, Seattle, Washington. · Divison of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Department of Urology, University of Washington, Seattle, Washington. Department of Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Department of Urology, University of Washington, Seattle, Washington. Department of Veterans Affairs Medical Center, Seattle, Washington. · Divison of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Medicine, University of Washington, Seattle, Washington. · Department of Urology, University of Washington, Seattle, Washington. · Pubmed 26071481
2014
  • Presented by Celestia S. Higano, MD, Professor, Departments of Medicine and Urology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington. · Pubmed 24853214
  • From the University of Washington, Seattle Cancer Care Alliance, Seattle, Washington. · Pubmed 24812139
  • Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology and Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, United States of America; Section of Urology, Portland VA Medical Center, Portland, Oregon, United States of America. · Department of Medicine, Oregon Health and Sciences University, Portland, Oregon, United States of America. · Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Pubmed 25198178
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of Washington, Seattle, WA. · Pubmed 24590651
  • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Urology, University of Washington School of Medicine, Seattle, Washington, United States of America. · Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America; Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, United States of America. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America. · Pubmed 25356728
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Mailstop G4-830, Seattle, WA 98109, USA. · Pubmed 24019065
2012
  • FACP, Seattle Cancer Care Alliance, Seattle, WA 98109-1023, USA. · Pubmed 23008326
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 21944872
2011
  • Department of Medicine, University of Washington School of Medicine, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Pubmed 22074657
2009
  • Department of Urology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 19111806
  • Department of Oncology and Urology, University of Washington, Seattle, WA, USA. · Pubmed 19536890
2008
  • University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 18185511
  • Department of Oncology, University of Washington Seattle, Seattle, Washington, USA. · Pubmed 18646045
  • Medicine and Urology, University of Washington Medical Center, Division of Medical Oncology, Seattle, WA 98109, USA. · Pubmed 18501082
2017
  • aSchool of Medicine bDepartment of Cell, Developmental and Cancer Biology cKnight Cancer Institute, Oregon Health and Science University Departments of dUrology and Radiation Medicine eSpecialty Medicine, VA Portland Health Care System, Portland, Oregon Departments of fImmunology gBreast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida Departments of hMedicine iUrology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA. · Pubmed 27669423
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From Roswell Park Cancer Institute; Duke Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Dana-Farber/Brigham and Women's Cancer Center; Mayo Clinic Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Prostate Health Education Network (PHEN); Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UC San Diego Moores Cancer Center; City of Hope Comprehensive Cancer Center; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Vanderbilt-Ingram Cancer Center; Moffitt Cancer Center; University of Colorado Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California San Francisco Patient Services Committee Chair; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26733552
  • David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · Pubmed 26811535
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 25732157
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Department of Medical Sciences (D.P.) and Biostatistics (E.R.), Amgen Inc (D.P.), Thousand Oaks, California 91320; Department of Medicine (C.S.H.), University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98109; Carolina Urologic Research Center, (N.D.S.), Myrtle Beach, South Carolina 29579; Urological Associates of Lancaster (P.S.), Lancaster, Pennsylvania 17604; and Massachusetts General Hospital Cancer Center (M.R.S.), Boston, Massachusetts 02114. · Pubmed 24971661
  • Amir Goldkorn, David I. Quinn, and Tong Xu, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles; Przemyslaw Twardowski, City of Hope, Duarte; Philip C. Mack and Primo Lara Jr, University of California, Davis, Sacramento, CA; Benjamin Ely and Catherine M. Tangen, Southwest Oncology Group Statistical Center; Celestia S. Higano, Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, and University of Washington, Seattle, WA; Louis M. Fink, Nevada Cancer Institute; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV; Peter J. Van Veldhuizen, University of Kansas Cancer Center, Westwood, KS; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Michael A. Carducci, Johns Hopkins Kimmel Cancer Center and Eastern Cooperative Oncology Group, Baltimore, MD; J. Paul Monk III, Ohio State University and Cancer and Leukemia Group B, Columbus, OH; Ram H. Datar and Richard J. Cote, University of Miami Miller School of Medicine, Miami, FL; Mark Garzotto, Portland Veterans Affairs Medical Center, Portland, OR; Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Ian Murchie Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 24616308
  • Authors' Affiliations: Knight Cancer Institute; Department of Public Health and Preventive Medicine; Knight Diagnostic Laboratories, Oregon Health and Science University; Portland VA Medical Center, Portland, Oregon; and Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, University of Washington, Seattle, Washington. · Pubmed 24352642
2013
  • From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network. · Pubmed 24335682
  • From the BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada; Dana-Farber Cancer Institute, Boston, MA; Univeristy of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 23714494
  • Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Pubmed 24098661
  • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 23420560
  • University of Washington and Fred Hutchinson Cancer Research Center, c/o Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 23341368
  • Department of Urology, University of Washington, Seattle, Washington 98195, USA. · Pubmed 23334979
  • Department of Urology, University of Washington, Seattle, WA 98195, USA. · Pubmed 22936276
2012
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Pubmed 22583636
  • University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 22493411
  • Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. · Pubmed 22921015
  • Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Pubmed 22863786
2011
  • Division of Oncology, Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Pubmed 21285676
  • Clinical Research Division, Fred Hutchinson Cancer Research Center, and Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA. · Pubmed 21471425
2010
  • Department of Medicine, Division of Oncology, University of Washington, 825 Eastlake Ave E., Seattle, WA 98109, USA. · Pubmed 20421544
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA. · Pubmed 20047689
  • Department of Medicine, University of Washington, Seattle, WA, USA. · Pubmed 19507029
2009
  • Department of Medicine, Division of Medical Oncology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 19371481
  • Divisions of Human Biology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA. · Pubmed 19773449
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98108, USA. · Pubmed 18636420
2008
  • Department of Pathology, University of Washington and Research Service, Seattle, Washington, USA. · Pubmed 18639279
  • Department of Medicine, University of Washington School of Medicine, Weattle, WA, USA. · Pubmed 18519708
  • Genitourinary Cancer Research Laboratory, Department of Urology, University of Washington, Seattle, WA 98195, USA. · Pubmed 17972146
2007
  • Division of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98105-1024, USA. · Pubmed 17908975
Probable:    University of British Columbia      
2017
  • Centre for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada. · Vancouver Prostate Centre, Gordon and Leslie Diamond Health Care Centre, Vancouver General Hospital, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Pubmed 28516513
2016
  • University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 27072384
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 25732157
Probable:    University of Michigan   Contact    
2016
  • Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Pubmed 26552421
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From Roswell Park Cancer Institute; Duke Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Dana-Farber/Brigham and Women's Cancer Center; Mayo Clinic Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Prostate Health Education Network (PHEN); Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UC San Diego Moores Cancer Center; City of Hope Comprehensive Cancer Center; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Vanderbilt-Ingram Cancer Center; Moffitt Cancer Center; University of Colorado Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California San Francisco Patient Services Committee Chair; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26733552
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Amir Goldkorn, David I. Quinn, and Tong Xu, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles; Przemyslaw Twardowski, City of Hope, Duarte; Philip C. Mack and Primo Lara Jr, University of California, Davis, Sacramento, CA; Benjamin Ely and Catherine M. Tangen, Southwest Oncology Group Statistical Center; Celestia S. Higano, Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, and University of Washington, Seattle, WA; Louis M. Fink, Nevada Cancer Institute; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV; Peter J. Van Veldhuizen, University of Kansas Cancer Center, Westwood, KS; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Michael A. Carducci, Johns Hopkins Kimmel Cancer Center and Eastern Cooperative Oncology Group, Baltimore, MD; J. Paul Monk III, Ohio State University and Cancer and Leukemia Group B, Columbus, OH; Ram H. Datar and Richard J. Cote, University of Miami Miller School of Medicine, Miami, FL; Mark Garzotto, Portland Veterans Affairs Medical Center, Portland, OR; Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Ian Murchie Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 24616308
2013
  • University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI 48109-0946, USA. · Pubmed 23550669
2009
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 133 total) written by Celestia S. Higano about Prostatic Neoplasms:

  • Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer. 2018
  • Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial. 2017
  • Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates. 2017
  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study. 2017
  • Evaluating an educational intervention to alleviate distress amongst men with newly diagnosed prostate cancer and their partners. 2017
  • LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics. 2017
  • Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL. 2017
  • Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database. 2017
  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. 2016
  • Prostate Cancer, Version 1.2016. 2016
Show List of Full Article Records
Google Searches

Learn more about Celestia S. Higano using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Washington
University of British Columbia
University of Michigan
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Washington
2018
  • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, University of Washington, Seattle, Washington. · Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · US Oncology, Las Vegas, Nevada. · Northwestern University, Feinberg School of Medicine, Chicago, Illinois. · CHRISTUS Santa Rosa Medical Center Hospital, San Antonio, Texas. · Departments of Internal Medicine and Biomedical Engineering, Center for Computational Medicine and Bioinformatics, Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan. · Pubmed 29105802
2017
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Centre for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada. · Vancouver Prostate Centre, Gordon and Leslie Diamond Health Care Centre, Vancouver General Hospital, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Pubmed 28516513
  • Department of Urology, University of Washington, Seattle, Washington. · Puget Sound Veteran Administration, Seattle, Washington. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Pubmed 28156002
  • Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA. · OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Clinical Medicine, Rigshospitalet, Copenhagen, Denmark. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Division of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Medical Oncology, Astellas Pharma, Inc., Northbrook, IL, USA. · Biostatistics, Astellas Pharma, Inc., Northbrook, IL, USA. · Pubmed 28117385
  • University of Colorado Cancer Center, Medical Oncology, Aurora, CO. Electronic address: · SmartAnalyst Inc., New York, NY. · Janssen Global Services, Global Medical Affairs, Raritan, NJ. · Janssen Global Services, Global Market Access Analytics, Raritan, NJ. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · Pubmed 27876504
2016
  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Electronic address: · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Cancer Centers of North Carolina, Raleigh, NC, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · University of Wisconsin Carbone Cancer Center, Madison, WI, USA. · Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Aragon Pharmaceuticals, San Diego, CA, USA. · Janssen Research & Development, Spring House, PA, USA. · Janssen Biologics, B.V., Leiden, The Netherlands. · Janssen Research & Development, Los Angeles, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Pubmed 27160947
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Clinical Development, OncoGenex Pharmaceuticals, Inc., Bothell, USA. · Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver. · Department of Medical Oncology, Juravinski Cancer Centre, Hamilton, Canada. · Pubmed 27022067
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Pubmed 26552421
  • Group Health Research Institute, Seattle, WA. · University of Washington, Seattle, WA. · University of Washington, Seattle, WA;; VA Puget Sound Health Services Research & Development, Seattle, WA. · University of Houston, Houston, TX. · Fred Hutchinson Cancer Research Center. · Pubmed 28269902
  • Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, Departments of Medicine and Urology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle. · Pubmed 27560985
  • Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington. · Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Pubmed 27324988
  • University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 27072384
  • Department of Urology, University of Washington, Seattle, Washington. · Fred Hutchinson Cancer Research Center, Seattle, Washington. · State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau (SAR), China. · Department of Pathology, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Department of Veterans Affairs Medical Center, Seattle, Washington. · Janssen Research and Development, LLC, Spring House, Pennsylvania. · Uniformed Services University of the Health Sciences, Rockville, Maryland. · Georgetown University Medical Center, Washington, District of Columbia. · Pubmed 26990456
  • Department of Genome Sciences, University of Washington, Seattle, Washington, USA. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Department of Urology, University of Washington, Seattle, Washington, USA. · Department of Pathology, University of Washington, Seattle, Washington, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Department of Medicine, University of Washington, Seattle, Washington, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Pubmed 26928463
  • Genitourinary Cancer Research Laboratory, Department of Urology, University of Washington, Box 356510, Seattle, WA, 98195, USA. · Divison of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Divison of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Pathology, University of Washington, Seattle, WA, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · Department of Veterans Affairs Medical Center, Seattle, WA, USA. · Genitourinary Cancer Research Laboratory, Department of Urology, University of Washington, Box 356510, Seattle, WA, 98195, USA. · Pubmed 26667932
2015
  • Department of Urologic Oncology, School of Medicine, University of Colorado Denver, Aurora, Colorado. Electronic address: · Division of Medical Oncology, Department of Medicine and Department of Urology, School of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Smilow Cancer Center, Yale University, New Haven, Connecticut. · Pubmed 26196735
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States. Electronic address: · Memorial Sloan-Kettering, New York, NY, United States. · University of Wisconsin, Carbone Cancer Center, Madison, WI, United States. · Duke Cancer Institute and Duke Prostate Center, Duke University, Durham, NC, United States. · Thomas Jefferson University, Philadelphia, PA, United States. · New York University Clinical Cancer Center, New York, NY, United States. · Sarah Cannon Research Institute, Nashville, TN, United States. · Eli Lilly and Company, Bridgewater, NJ, United States. · Eli Lilly and Company, Indianapolis, IN, United States. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. · Pubmed 26082390
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • University of Washington, Seattle, Washington · Department of Biostatistics and Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island. · University of Washington, Seattle, Washington. · Duke University, Durham, North Carolina. · Oregon Health & Science University, Portland, Oregon. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Pennsylvania, Philadelphia, Pennsylvania. · American College of Radiology Imaging Network (ACRIN), Philadelphia, Pennsylvania; and. · University of California San Francisco, San Francisco, California. · Pubmed 25635138
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • Case Western Reserve University School of Medicine, Cleveland, OH. · Fred Hutchinson Cancer Research Center, Biostatistics and Biomathematics Program, Public Health Sciences Division, Seattle, WA. · University of Washington/Fred Hutchinson Cancer Research Center, Department of Medicine, Division of Oncology, Seattle, WA. · University of Washington/Fred Hutchinson Cancer Research Center, Department of Medicine, Division of Oncology, Seattle, WA. Electronic address: · Pubmed 25242417
  • Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Program, Massachusetts General Hospital, Boston, MA, USA. · Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Clinical Development, Exelixis, Inc., South San Francisco, CA, USA. · Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Genitourinary Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Urologic Surgery and Oncology, University of California San Francisco, San Francisco, CA, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pinnacle Oncology Hematology, Scottsdale, AZ, USA. · Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24631409
  • Departments of Medicine and Urology, University of Washington, 825 Eastlake Avenue East, Seattle, WA 98109-1023, USA. · Pubmed 26526753
  • Institute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan. · Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan. · Department of Urology, JCHO Tokyo Shinjuku Medical Center, Japan Community Health Care Organization Tokyo, Japan. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Institute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan; Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan; Graduate School of Engineering, The University of Tokyo, Tokyo, Japan. · Pubmed 26107379
  • Department of Urology, University of Washington, Seattle, Washington. · Divison of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Department of Urology, University of Washington, Seattle, Washington. Department of Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Department of Urology, University of Washington, Seattle, Washington. Department of Veterans Affairs Medical Center, Seattle, Washington. · Divison of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Medicine, University of Washington, Seattle, Washington. · Department of Urology, University of Washington, Seattle, Washington. · Pubmed 26071481
2014
  • Presented by Celestia S. Higano, MD, Professor, Departments of Medicine and Urology, University of Washington/Seattle Cancer Care Alliance, Seattle, Washington. · Pubmed 24853214
  • From the University of Washington, Seattle Cancer Care Alliance, Seattle, Washington. · Pubmed 24812139
  • Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology, University of Washington, Seattle, Washington, United States of America. · Department of Urology and Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, United States of America; Section of Urology, Portland VA Medical Center, Portland, Oregon, United States of America. · Department of Medicine, Oregon Health and Sciences University, Portland, Oregon, United States of America. · Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Urology, University of Washington, Seattle, Washington, United States of America. · Pubmed 25198178
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of Washington, Seattle, WA. · Pubmed 24590651
  • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Urology, University of Washington School of Medicine, Seattle, Washington, United States of America. · Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America; Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, United States of America. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America. · Pubmed 25356728
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Mailstop G4-830, Seattle, WA 98109, USA. · Pubmed 24019065
2012
  • FACP, Seattle Cancer Care Alliance, Seattle, WA 98109-1023, USA. · Pubmed 23008326
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 21944872
2011
  • Department of Medicine, University of Washington School of Medicine, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Pubmed 22074657
2009
  • Department of Urology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 19111806
  • Department of Oncology and Urology, University of Washington, Seattle, WA, USA. · Pubmed 19536890
2008
  • University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 18185511
  • Department of Oncology, University of Washington Seattle, Seattle, Washington, USA. · Pubmed 18646045
  • Medicine and Urology, University of Washington Medical Center, Division of Medical Oncology, Seattle, WA 98109, USA. · Pubmed 18501082
2017
  • aSchool of Medicine bDepartment of Cell, Developmental and Cancer Biology cKnight Cancer Institute, Oregon Health and Science University Departments of dUrology and Radiation Medicine eSpecialty Medicine, VA Portland Health Care System, Portland, Oregon Departments of fImmunology gBreast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida Departments of hMedicine iUrology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA. · Pubmed 27669423
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From Roswell Park Cancer Institute; Duke Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Dana-Farber/Brigham and Women's Cancer Center; Mayo Clinic Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Prostate Health Education Network (PHEN); Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UC San Diego Moores Cancer Center; City of Hope Comprehensive Cancer Center; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Vanderbilt-Ingram Cancer Center; Moffitt Cancer Center; University of Colorado Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California San Francisco Patient Services Committee Chair; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26733552
  • David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · Pubmed 26811535
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 25732157
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Department of Medical Sciences (D.P.) and Biostatistics (E.R.), Amgen Inc (D.P.), Thousand Oaks, California 91320; Department of Medicine (C.S.H.), University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98109; Carolina Urologic Research Center, (N.D.S.), Myrtle Beach, South Carolina 29579; Urological Associates of Lancaster (P.S.), Lancaster, Pennsylvania 17604; and Massachusetts General Hospital Cancer Center (M.R.S.), Boston, Massachusetts 02114. · Pubmed 24971661
  • Amir Goldkorn, David I. Quinn, and Tong Xu, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles; Przemyslaw Twardowski, City of Hope, Duarte; Philip C. Mack and Primo Lara Jr, University of California, Davis, Sacramento, CA; Benjamin Ely and Catherine M. Tangen, Southwest Oncology Group Statistical Center; Celestia S. Higano, Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, and University of Washington, Seattle, WA; Louis M. Fink, Nevada Cancer Institute; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV; Peter J. Van Veldhuizen, University of Kansas Cancer Center, Westwood, KS; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Michael A. Carducci, Johns Hopkins Kimmel Cancer Center and Eastern Cooperative Oncology Group, Baltimore, MD; J. Paul Monk III, Ohio State University and Cancer and Leukemia Group B, Columbus, OH; Ram H. Datar and Richard J. Cote, University of Miami Miller School of Medicine, Miami, FL; Mark Garzotto, Portland Veterans Affairs Medical Center, Portland, OR; Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Ian Murchie Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 24616308
  • Authors' Affiliations: Knight Cancer Institute; Department of Public Health and Preventive Medicine; Knight Diagnostic Laboratories, Oregon Health and Science University; Portland VA Medical Center, Portland, Oregon; and Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, University of Washington, Seattle, Washington. · Pubmed 24352642
2013
  • From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network. · Pubmed 24335682
  • From the BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada; Dana-Farber Cancer Institute, Boston, MA; Univeristy of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 23714494
  • Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Pubmed 24098661
  • Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 23420560
  • University of Washington and Fred Hutchinson Cancer Research Center, c/o Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 23341368
  • Department of Urology, University of Washington, Seattle, Washington 98195, USA. · Pubmed 23334979
  • Department of Urology, University of Washington, Seattle, WA 98195, USA. · Pubmed 22936276
2012
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Pubmed 22583636
  • University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Pubmed 22493411
  • Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. · Pubmed 22921015
  • Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Pubmed 22863786
2011
  • Division of Oncology, Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. · Pubmed 21285676
  • Clinical Research Division, Fred Hutchinson Cancer Research Center, and Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA. · Pubmed 21471425
2010
  • Department of Medicine, Division of Oncology, University of Washington, 825 Eastlake Ave E., Seattle, WA 98109, USA. · Pubmed 20421544
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA. · Pubmed 20047689
  • Department of Medicine, University of Washington, Seattle, WA, USA. · Pubmed 19507029
2009
  • Department of Medicine, Division of Medical Oncology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA 98109, USA. · Pubmed 19371481
  • Divisions of Human Biology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA. · Pubmed 19773449
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98108, USA. · Pubmed 18636420
2008
  • Department of Pathology, University of Washington and Research Service, Seattle, Washington, USA. · Pubmed 18639279
  • Department of Medicine, University of Washington School of Medicine, Weattle, WA, USA. · Pubmed 18519708
  • Genitourinary Cancer Research Laboratory, Department of Urology, University of Washington, Seattle, WA 98195, USA. · Pubmed 17972146
2007
  • Division of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98105-1024, USA. · Pubmed 17908975
University of British Columbia
2017
  • Centre for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada. · Vancouver Prostate Centre, Gordon and Leslie Diamond Health Care Centre, Vancouver General Hospital, Vancouver, BC, Canada. · School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Pubmed 28516513
2016
  • University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada · University of Washington, Seattle, WA; University of British Columbia; and Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 27072384
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Laurence Klotz, Sunnybrook Health Sciences Centre, University of Toronto; Mary Gospodarowicz, Princess Margaret Hospital, Toronto; Chris O'Callaghan and Keyue Ding, Queen's University, Kingston; Shawn Malone, Ottawa Regional Cancer Centre, Ottawa, Ontario; Paul Toren, Larry Goldenberg, and Juanita M. Crook, University of British Columbia, Vancouver, British Columbia, Canada; David Dearnaley, Royal Marsden Hospital, London, United Kingdom; Celestia S. Higano, Fox Chase Cancer Center, Philadelphia, PA; and Eric Horwitz, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 25732157
University of Michigan
2016
  • Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Pubmed 26552421
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From Roswell Park Cancer Institute; Duke Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Dana-Farber/Brigham and Women's Cancer Center; Mayo Clinic Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Prostate Health Education Network (PHEN); Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UC San Diego Moores Cancer Center; City of Hope Comprehensive Cancer Center; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Vanderbilt-Ingram Cancer Center; Moffitt Cancer Center; University of Colorado Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California San Francisco Patient Services Committee Chair; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26733552
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Amir Goldkorn, David I. Quinn, and Tong Xu, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles; Przemyslaw Twardowski, City of Hope, Duarte; Philip C. Mack and Primo Lara Jr, University of California, Davis, Sacramento, CA; Benjamin Ely and Catherine M. Tangen, Southwest Oncology Group Statistical Center; Celestia S. Higano, Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, and University of Washington, Seattle, WA; Louis M. Fink, Nevada Cancer Institute; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV; Peter J. Van Veldhuizen, University of Kansas Cancer Center, Westwood, KS; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Michael A. Carducci, Johns Hopkins Kimmel Cancer Center and Eastern Cooperative Oncology Group, Baltimore, MD; J. Paul Monk III, Ohio State University and Cancer and Leukemia Group B, Columbus, OH; Ram H. Datar and Richard J. Cote, University of Miami Miller School of Medicine, Miami, FL; Mark Garzotto, Portland Veterans Affairs Medical Center, Portland, OR; Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Ian Murchie Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 24616308
2013
  • University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI 48109-0946, USA. · Pubmed 23550669
2009
University of Texas Health Science Center San Antonio
2016
  • Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Catherine Tangen, SWOG Statistical Center; Celestia Higano, University of Washington, Seattle, WA; Nicholas Vogelzang, US Oncology, Las Vegas, NV; and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Pubmed 26552421
2016
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
2014
  • Amir Goldkorn, David I. Quinn, and Tong Xu, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles; Przemyslaw Twardowski, City of Hope, Duarte; Philip C. Mack and Primo Lara Jr, University of California, Davis, Sacramento, CA; Benjamin Ely and Catherine M. Tangen, Southwest Oncology Group Statistical Center; Celestia S. Higano, Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, and University of Washington, Seattle, WA; Louis M. Fink, Nevada Cancer Institute; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV; Peter J. Van Veldhuizen, University of Kansas Cancer Center, Westwood, KS; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Michael A. Carducci, Johns Hopkins Kimmel Cancer Center and Eastern Cooperative Oncology Group, Baltimore, MD; J. Paul Monk III, Ohio State University and Cancer and Leukemia Group B, Columbus, OH; Ram H. Datar and Richard J. Cote, University of Miami Miller School of Medicine, Miami, FL; Mark Garzotto, Portland Veterans Affairs Medical Center, Portland, OR; Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Ian Murchie Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 24616308
Miscellaneous institutions in Seattle
2014
  • Princess Margaret Hospital, Toronto, ON, Canada. Electronic address: · Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA. · BC Cancer Agency, Vancouver, BC, Canada. · Seattle Cancer Centre Alliance, Seattle, WA, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Royal Marsden NHS Foundation Trust, Sutton, UK. · Tulane Cancer Center, New Orleans, LA, USA. · University of Montreal Hospital Center, Montreal, PQ, Canada. · Pubmed 23957948
76 Other Locations Show
Yearly article counts 17161818151341012910